Navigation Links
Global Biotech and Pharmaceutical Conference Early Bird Registration Discounts End This Week
Date:9/12/2012

FARMINGTON, Conn., Sept. 12, 2012 /PRNewswire-iReach/ -- Bio-IT World Expo Europe 2012 October 9-11, 2012 - Vienna, Austria

(Photo: http://photos.prnewswire.com/prnh/20120912/CG73074)

The Fourth Annual Bio-IT World Europe Conference & Expo attracts life sciences, pharmaceutical, informatics and IT professionals from across Europe and the rest of the world. This year's conference will feature four tracks: Clinical Genomics; Data Infrastructure and High Performance Computing; Drug Discovery Informatics to Personalized Therapeutics; and Cloud-Based Bioinformatics. A unique opportunity to share research advances, information trends and new enabling technologies that are driving biomedical research and drug development.

Keynote speakers are to include Yike Guo, Ph.D., Professor of Computing Science at Imperial College London; Ian Dix, Ph.D., Director of Analytics, Information and Knowledge Engineering (AIKE), and R&D Information at AstraZeneca; Paul Flicek, Ph.D., Principal Investigator & Head of Vertebrate Genomics Team, EMBL-European Bioinformatics Institute; Hermann Hauser, Entrepreneur and Partner at Amadeus Capital Partners; Eric D. Perakslis, Ph.D., CIO and Chief Scientist of Informatics at the U.S. Food and Drug Administration (FDA); Alison Davis, Director of Information Management at the Medicines and Healthcare Products Regulatory Agency (MHRA); and Luc Verhelst, CIO at  the European Medicines Agency (EMA).

Early bird discounts expire this week, register through GII to save nearly $200 before September 14 at http://www.giiconference.com/chi229590-2012/

PK/PD of Novel Constructs
October 10 - 12, 2012 - Bethesda, MD, USA

Understanding the activity of novel constructs in animal models and clinical studies is critical to their success. There are numerous constructs of bispecific and multiclonal antibodies, antibody-drug conjugates, and antibody fragments heading to the clinic that are diverse in nature. This conference will delve into tools for understanding effects in humans and engineering for optimal efficacy, safety and metabolism, and strive to uncover the link between immunogenicity and pK/pD.

Keynote speakers are to include Louis M. Weiner, M.D., Director, Lombardi Comprehensive Cancer Center; Professor and Chair, Department of Oncology, Georgetown University Medical Center; Joseph P. Balthasar, Ph.D., Professor, Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, SUNY Buffalo; and Vibha Jawa, Ph.D., Principal Scientist, Clinical Immunology, Amgen

Early bird discounts expire this week, register through GII to save $200 before September 14 at http://www.giiconference.com/chi240526-2012/

Immunogenicity Summit 2012
10-12 October 2012 - Bethesda, MD, USA

The Leading Summit Connecting Industry, Academia and Regulators on Immunogenicity Testing, Immunogenicity Avoidance and Regulatory Guidance

Following year-on-year success, CHI presents their fourth Immunogenicity Summit. We will continue to provide strong interaction and discussion with the regulatory authorities (40 FDA representatives in 2011), updates on immunogenicity testing strategies and means of controlling immunogenicity. New this year will be a focus on characterization and impact of immune complexes, in vivo assessment with immune tolerant mice, and anti-idiotype assays for hypersensitivity.  Last year's attendance was up by 20% with over 250 attendees representing over 50 global organizations.

Keynote & featured Speakers are to include: Steve J. Swanson, Ph.D., Director, Medical Sciences, Clinical Immunology, Amgen; Amy Rosenberg, M.D., Director, Therapeutic Proteins, CDER/FDA; Susan Kirshner, Ph.D., Associate Chief, Laboratory of Immunology, Therapeutic Proteins, Biotechnology, CDER/FDA; Daniela Verthelyi, M.D., Ph.D., Chief, Immunology, Therapeutics Proteins, CDER/FDA; Jack Ragheb, M.D., Ph.D., Principal Investigator, Immunology, Therapeutic Proteins, CDER/FDA; Paul Chamberlain, NDA Advisory Board; Roy Jefferis, Ph.D., C.Chem, FRSC, MRCP, FRCPath, D.S., Professor Emeritus, School of Immunity & Infection, University of Birmingham UK; and Valerie Quarmby, Ph.D., Director and Principal Scientist, BioAnalytical Sciences, Genentech, Inc.

Early bird discounts expire this week, register through GII to save nearly $200 before September 14 at http://www.giiconference.com/chi240525-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Novo Nordisk and BGI establish global collaboration framework
2. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
3. Global warming threat to coral reefs: Can some species adapt?
4. 1 solution to global overfishing found
5. Young researcher taking fight against global killer to the next level in Vietnam
6. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
7. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
8. Global effort launched to save turtles from extinction
9. New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
10. 2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
11. Desert to Rainforest global classroom links future teachers, classrooms in Phoenix and Panama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... , ... June 21, 2017 , ... Building on the ... inspiring, and more informative on the very latest developments in radical life extension. RAADfest ... of a festival, and the empowerment of personal development, making it the largest most ...
(Date:6/22/2017)... ... 2017 , ... The first human cell line HeLa, established in 1951, has ... cross-contamination of human cell lines with HeLa cells were published. Until recently, cross-contamination and ... and is associated with dramatic consequences for research. , In this educational webinar, ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... to immediately determine the adulterants which pose the most likely threat to their ... 28 of this year. , IFT's annual food expo attracts over 20,000 ...
(Date:6/19/2017)... ... 19, 2017 , ... As Vice President, Product Services, Mr. ... implementation, support, and client process and SOP development. , Mr. Guinter brings a ... roles for service providers and top-tier pharmaceuticals, and as an independent consultant supported ...
Breaking Biology Technology: